|
Quotes & Info
|
| BSTC > SEC Filings for BSTC > Form 8-K on 27-Jun-2012 | All Recent SEC Filings |
27-Jun-2012
Other Events, Financial Statements and Exhibits
On June 26, 2012, the Company issued a press release announcing the initiation of its Phase II trial of XIAFLEX for the treatment of human lipomas.
A press release regarding the announcement is attached hereto as Exhibit 99.1.
(d) Exhibits
99.1 Press release dated June 26, 2012
|
|